KDEV INVESTMENTS

KDev Investments

#Financial #More

KDEV INVESTMENTS

Status:
Active


Investments List

Date Company Article Money raised
2017-02-20 Modus Therapeutics KDev Investments investment in Venture Round - Modus Therapeutics 32 M SEK

More informations about "KDev Investments"

KDev Investments AB - Företagsinformation - allabolag.se

KDev Investments AB,556880-1608 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för KDev Investments ABSee details»

Karolinska Development as an investment

The returns from KDev Investmentsโ€™ holdings, including Rosetta Capitalโ€™s investments in portfolio companies, will be distributed in accordance with a so-called waterfall structure, as illustrated โ€ฆSee details»

KDev Investments - Crunchbase Investor Profile & Investments

Feb 20, 2017 Modus Therapeutics raised SEK32,000,000 / Series Unknown from KDev Investments and 3 other investors . Discover more funding rounds . Details. Edit Details โ€ฆSee details»

Kdev Investments AB Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Kdev Investments AB of Solna, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»

KDev Investments AB | Aktiebolag | Info & Löner - Bolagsfakta

KDev Investments AB โ€“ Org.nummer: 556880-1608. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m.See details»

Karolinska - Crunchbase Investor Profile & Investments

Return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products. Karolinska Development has developed a well-structured selection process to identify the โ€ฆSee details»

Karolinska Development som investering

Avkastningen från KDev Investments innehav, inklusive Rosetta Capitals investeringar i portföljbolagen, kommer fördelas enligt en så kallad vattenfallsstruktur, vilken illustreras i โ€ฆSee details»

KDev Investments AB i Solna โ€“ Info - Ratsit

Mar 20, 2025 KDev Investments AB - Org.nummer: 5568801608. Fördelningen i styrelsen är 100,0 % män (2), 0,0 % kvinnor (0) . Ansvarig är Viktor Drvota 59 år. På Ratsit hittar du โ€ฆSee details»

KDev Investments - Investments, Portfolio & Company Exits

KDev Investments has invested in Modus Therapeutics on Feb 20, 2017. This investment - Venture Round ... obfuscated. obfuscated. How many investments has this organization made โ€ฆSee details»

Karolinska Development โ€“ Wikipedia

KDev Investments AB (med Rosetta Capital) Karolinska Development AB är ett svenskt investmentföretag för läkemedels- och biotekniska företag. Det grundades 2003 för att โ€ฆSee details»

KDev Investments AB - Drug pipelines, Patents, Clinical trials

Explore KDev Investments AB with its drug pipeline, therapeutic area, technology platform, 5 news.See details»

Karolinska Development AB, KDEV:STO profile - FT.com

Karolinska Development AB is a Sweden-based investment company. The Company provides capital to biotechnology firms, as well as develops and commercializes biotechnological โ€ฆSee details»

Karolinska Development AB (publ) | Globenewswire

Oct 12, 2024 Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on identifying breakthrough medical innovations โ€ฆSee details»

KDev Investments AB - Koncernstruktur - allabolag.se

KDev Investments AB,556880-1608 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status. INFORMATION. På torsdag den 12 september är vår โ€ฆSee details»

Company Karolinska Development AB - MarketScreener.com

Nov 27, 2017 KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and โ€ฆSee details»

KDEV | Karolinska Development AB Stock Overview (Sweden

Its portfolio investments include Umecrine Cognition, Forendo Pharma, OssDsign, Modus Therapeutics, Dilafor, Aprea Therapeutics, Lipidor, Promimic, and Asarina Pharma. The โ€ฆSee details»

Karolinska Development divests 4,6 million shares in

Oct 12, 2024 Karolinska Development AB (Nasdaq Stockholm: KDEV) divests 4,6 million shares in the portfolio company OssDsign and thereby strengthens the investment companyโ€™s liquidity.See details»

KDev Investments AB Stock Data, Filings, Earnings, News

Get the latest news, data and filings for KDev Investments AB, with free alerts. Includes transcripts, social sentiment, and more.See details»

KDev Investments AB - Bolagshändelser - allabolag.se

KDev Investments AB,556880-1608 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, StatusBolagshändelser för KDev Investments ABSee details»

Karolinska Development (KDEV) Investor Relations Material

Nov 15, 2024 Access Karolinska Development (KDEV) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr ... Karolinska โ€ฆSee details»